Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.
Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.